DentiMax, a leader in dental technology solutions, is thrilled to announce the launch of DentiMax Flow, innovative browser-based practice management software designed to transform the way dental practices operate. Built to meet the dynamic needs of modern dental offices, DentiMax Flow gives dental professionals access to their entire software suite, including appointments, patient records, billing, reports, SMS, documents and more from any device that has an internet connection.

With over 20 years of experience in dental software development, DentiMax is a trusted partner for thousands of dental practices. DentiMax Flow is a major advancement in their product offerings, combining seamless cloud accessibility with a powerful, friendly interface.

“DentiMax Flow is the culmination of years of hard work and listening closely to our clients' needs,” said Lee Varney, Co-Founder and CTO of DentiMax. “With DentiMax Flow, we have created a solution that not only increases efficiency but also enhances the patient experience. It’s a flexible, scalable platform that grows with practices, big or small, and makes the day-to-day operations of running a dental office easier.”

Starting out at only $199 per month, DentiMax Flow is available with additional pricing options tailored to meet the needs of practices of all sizes. DentiMax is also offering demonstrations and onboarding support to ensure a smooth transition for new clients.

Key features of DentiMax Flow include the following:

• Accessible from virtually any device, including smart phones, Macs, PCs, iPads, tablets and any other device that has a web browser.

• Insightful dashboard that provides KPI’s and facilitates your front and back-office workflow in a way that mirrors your patient experience.

• Easy-to-use design that allows your staff to complete complex tasks, like sending claims with attachments or digital referrals, in a friendly manner.

• Complete feature set that includes appointments scheduling, treatment planning, clinical notes, insurance eligibility, credit cards processing, customizable reports, comprehensive analytics and much more.

For more information about DentiMax Flow or to schedule a demo, visit www.dentimax.com/flow or contact DentiMax's sales team at 800-704-8494.

In an open letter to the healthcare community released today, American Dental Hygienists’ Association (ADHA®) President Erin Haley-Hitz, RDH, issued a strong objection to recently passed American Dental Association (ADA) resolutions that would eliminate faculty-to-student ratios in dental hygiene programs and allow unlicensed practitioners to perform dental hygiene services.

“The proposed measures outlined in these resolutions threaten professional integrity and patient outcomes, and fundamentally undermine the dental hygiene profession,” said Haley-Hitz. “ADHA strongly believes that rather than diminishing professional standards and undermining a complementary profession, constructive efforts should be directed toward improving workplace culture, enhancing professional development opportunities, and offering competitive benefits.”

The full text of President Haley-Hitz’s letter follows:

Dear Colleagues and Members of the Healthcare Community,

2024-2025 ADHA President

About the American Dental Hygienists’ Association

The American Dental Hygienists’ Association (ADHA) is the only organization representing the professional interests of the more than 220,000 dental hygienists in the United States. Dental hygienists are preventive oral health professionals, licensed in dental hygiene, who provide educational, clinical and therapeutic services that support total health through the promotion of optimal oral health. The Journal of Dental Hygiene (JDH), published bi-monthly, is ADHA’s scientific journal and flagship publication. To learn more about the ADHA, dental hygiene or the link between oral health and general health, visit adha.org.

Pictured: In a letter, the American Dental Hygienists’ Association calls for collaborative workforce solutions rather than compromising standards and patient safety through unlicensed practice.

The NYU College of Dentistry will host its third AHEAD Symposium on Wednesday, November 13, 2024, from 9:00 AM to 12:00 PM ET. The virtual event, titled “Achieving Health Equity through Access for All with Disabilities,” will bring together policymakers, experts, and advocates to address the critical issue of oral health care access for people with disabilities.

Dental care remains the most unmet healthcare need for individuals with disabilities, with patients and their families facing numerous barriers to receiving care. Challenges include inadequate insurance coverage, insufficient reimbursement policies, a shortage of providers trained in disability-focused care, and dental offices that lack the necessary accommodations for patients with certain disabilities.

To address these challenges, NYU Dentistry established the Oral Health Center for People with Disabilities five years ago. This state-of-the-art clinic is staffed by a compassionate, multidisciplinary team committed to providing comprehensive dental care tailored to the unique needs of patients with disabilities. Additionally, all NYU dental students receive training in disability care, and the College leads several continuing education programs aimed at improving oral health care practices for dentists and other health professionals.

The symposium’s keynote speakers include:

• Jim Brett, Chair of the President’s Committee for People with Intellectual Disabilities, who also serves as President and CEO of the New England Council.

• Congressman Seth Moulton (D-MA 6th District), sponsor of the bipartisan Healthcare Extension and Accessibility for Developmentally Disabled and Underserved Population (HEADs UP) Act, which seeks to expand and improve healthcare services for people with disabilities.

• Kim Hill Ridley, New York State’s first-ever Chief Disability Officer.

• Kate Swenson, a parent advocate and author of “Finding Cooper’s Voice,” a blog focused on the challenges and joys of raising a child with autism.

In addition to the keynote addresses, the event will feature panel discussions on the importance of integrated care for individuals with special health care needs and alternative models of support services that ensure better health outcomes for people with disabilities.

The AHEAD Symposium is free and open to the public, with prior registration required. To register for the event and view a full schedule, visit [dental.nyu.edu/ahead](https://dental.nyu.edu/ahead).

Accessibility

This virtual event will feature closed captioning for all audio presentations. Attendees will need an internet connection and a computer or smartphone to participate. For any additional accommodation requests, please contact the event organizers at dental.web@nyu.edu by November 8, 2024.

By bringing together experts from various fields, the AHEAD Symposium aims to drive forward the conversation on how to make oral health care more accessible and equitable for people with disabilities.

More information is available on the NYU College of Dentistry’s event page, https://dental.nyu.edu/ahead.

Pac-Dent, Inc. is excited to announce the launch of Rodin® Glaze N2-Free and Rodin® Palette N2-Free Naturalizing Kit, a groundbreaking resin characterization system set to redefine the staining and glazing procedure for printed dental restorations. This innovative system has been designed for surface detailing across a wide range of dental restorations, including hybrid ceramics, PMMA resins, and CAD/CAM composites, ensuring compatibility with various workflows.

Rodin® Glaze N2-Free offers a new level of restoration finishing by neutralizing the oxygen inhibition layer, ensuring complete polymerization without the tacky surface commonly caused by oxygen exposure during the curing process. Designed to enhance durability, Rodin® Glaze N2-Free offers a high-gloss, natural-looking finish that resists discoloration, staining, and mechanical wear, ensuring long-lasting, lifelike restorations. With curing times ranging from as little as 40 seconds to a few minutes based on device settings, Rodin® Glaze N2-Free allows clinicians to seamlessly integrate this new technology into existing workflows, enhancing both efficiency and patient satisfaction.

The inclusion of Rodin® Glaze N2-Free in the Rodin® Palette N2-Free Naturalizing Kit enhances the system's versatility across various workflows. This upgraded, comprehensive light-curable staining system elevates the esthetic quality of dental restorations. With an expanded shade range, the kit offers precise color matching, seamlessly blending restorations with the patient’s natural dentition. Engineered for broad compatibility across multiple curing methods—including handheld light curing for direct intraoral applications—this new system simplifies chairside workflows and maximizes flexibility in clinical settings.

Key benefits and features of Rodin® Glaze N2-Free and Rodin® Palette N2-Free Naturalizing Kit:

• Superior Esthetics: Provides a high-gloss, natural translucency that closely mimics enamel, ensuring vibrant, lifelike restorations that blend seamlessly with natural dentition.

• Enhanced Durability: Protects restorations from mechanical forces and wear, sealing micro-fractures and pits to ensure restorations retain both their esthetic and functional qualities over time.

• Odorless: The MMA-free formula ensures the glaze is pleasantly neutral in scent and taste, providing a more comfortable experience and enhancing patient satisfaction during treatment.

• Workflow Efficiency: Designed for ease of use, integrates into various curing workflows. The glaze enables both intraoral and extraoral curing, simplifying chairside application and enhancing treatment efficiency.

For more information on Rodin® Glaze N2-Free and Rodin® Palette N2-Free, please visit the product pages at https://www.rodin-3d.com/

About Pac-Dent, Inc.:

Pac-Dent, Inc. is a rapidly expanding provider of premium dental products, renowned for over 30 years of commitment to quality and innovation in oral health care. Established in 1992, Pac-Dent leads the industry with advanced solutions across preventive care, 3D resins, restoratives, teeth whitening, endodontics, and infection control, delivering essential products to dental professionals globally.

Dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL) and VideaHealth, Inc. (“VideaHealth”), a leader in dental AI solutions, on Nov. 4 announced a strategic partnership that will allow Dentalcorp to deploy artificial intelligence technology to advance patient care across its nationwide network of dental practices. This partnership marks a notable milestone in Dentalcorp's long-term growth agenda and is expected to allow the Company to set new benchmarks for clinical excellence and operational efficiency across its network.

By integrating VideaHealth’s AI-powered technology into Dentalcorp’s existing suite of digital solutions, Dentalcorp expects to realize the following benefits across its network:

• Comprehensive detection of dental conditions, leading to earlier interventions and improved patient outcomes.

• Improved patient education and engagement through AI-generated visual aids and explanations, leading to higher case acceptance rates.

• Streamlined clinical workflows, allowing dental professionals to operate more efficiently.

• Enhanced consistency in diagnoses across practitioners, reducing variability in care.

• Advanced prediction of disease progression to better assess patient risk and inform treatment planning.

“We have always been committed to providing our practices with best-in-class technology to support superior patient care. We believe that our partnership with VideaHealth represents a significant step forward in our ongoing efforts to transform our network. By leveraging AI, we expect to not just improve diagnostics, but enhance the entire patient experience and support our practitioners in delivering the highest standard of care,” said Graham Rosenberg, Founder and CEO of Dentalcorp.

Dentalcorp’s decision to partner with VideaHealth follows an extensive pilot program where a select group of Dentalcorp practices rigorously evaluated various AI solutions across a number of clinical, operational, financial and regulatory factors. VideaHealth’s advanced AI capabilities, robust data protection measures and established industry relationships, contributed to their impressive performance across every dimension during this pilot program and made them the ideal partner for this next phase of Dentalcorp’s growth plan.

“We are thrilled to partner with Dentalcorp, a leader in the Canadian dental industry. Our shared vision of leveraging technology to improve oral health aligns perfectly. By combining Dentalcorp's extensive network and commitment to excellence with our AI expertise, we will be setting a new standard for dental care in Canada and beyond,” said Florian Hillen, CEO and Founder of VideaHealth.

About Dentalcorp

Dentalcorp is Canada’s largest and one of North America’s fastest growing networks of dental practices, committed to advancing the overall well-being of Canadians by delivering the best clinical outcomes and leading experiences. Dentalcorp acquires leading dental practices, uniting its network in a common goal: to be Canada’s most trusted healthcare network. Leveraging its industry-leading technology, know-how and scale, Dentalcorp offers professionals the opportunity to retain their clinical autonomy while unlocking their potential for future growth. To learn more, visit Dentalcorp.ca.

About VideaHealth

VideaHealth is at the forefront of bringing AI to dentistry, partnering with dental professionals to improve patient care, strengthen patient relationships, and drive practice growth. VideaHealth's AI-powered platform is used by dental professionals across North America to analyze millions of patients annually, supporting clinicians in identifying and treating critical dental conditions. Headquartered in Boston and backed by leading venture capital firms, VideaHealth is committed to transforming dental care through innovative AI solutions. For more information, visit videa.ai.

Productive Dentist Academy (PDA), the leading dental consulting and marketing firm in the nation, invites dental professionals to “Tap In” to the highly anticipated PDA Conference from March 13-15, 2025, at the Hyatt Regency in Frisco, Texas. This two-and-a-half-day event brings together dental professionals who seek to increase productivity, optimize overhead, eliminate staff headaches, streamline patient communication, and re-energize the practice. So, doctors can give patients the care they deserve at a pace that doesn’t lead to burnout.

“For more than 20 years, PDA has helped guide dentists who face everything from scheduling woes to changing patient expectations,” says PDA Co-founder & CEO Victoria Peterson, S.s.D. “At PDA, we believe that by building an Investment Grade Practice™, doctors can combine high productivity with high-quality patient care. This conference’s ‘Tap In’ theme reflects the proven tools, strategies, and frameworks attendees can get to overcome daily challenges, build resilience, and create meaningful patient relationships.”

Conference Highlights

Attendees will experience two and a half days of focused workshops, insightful breakout sessions, and powerful networking opportunities to deliver immediate growth and long-term value. The March 2025 PDA Conference's all-encompassing curriculum can help dental professionals:

• Tap Into Productivity: Streamline workflows, optimize schedules, and achieve higher profitability to elevate the patient experience and reduce clinician burnout.

• Tap Into Patient Trust: Learn to cultivate authentic patient relationships, increase case acceptance, and build long-term loyalty.

• Tap Into Leadership: Discover the mindset and methods that foster a thriving team culture, align practice goals with personal values, and inspire employee accountability.

The Hyatt Regency in Frisco, Texas, offers attendees a premium experience, with easy access to the Stonebriar Centre’s dining and entertainment options.

“When doctors leave our conference, they're ready to implement changes on Monday morning,” says PDA Co-founder Dr. Bruce B. Baird. “They return home with concrete strategies for sustainable growth and the communication skills to strengthen patient relationships and team dynamics.”

Registration is now open! Doctors can register for $2,195, and team members for $1,495. Flexible payment options are available. To reserve your spot, visit www.productivedentist.com/March2025Conference/ or call PDA VP of Client Services, Brent Hogan, at 800-757-6077 ext. 135.

For more information about Productive Dentist Academy or the PDA Conference, please visit www.productivedentist.com.

About Productive Dentist Academy

Productive Dentist Academy (PDA) is an award-winning dental business and marketing consulting firm based in Anacortes, WA. At PDA, we know independent dentists are uncertain about the future of private practice and are concerned there may be no other option than to sell to a dental service organization (DSO). That's why PDA built the Investment Grade Practice™ platform to be the advocate and level the playing field so independent dentists can optimize profitability, improve patient experience, and align teams to the dentist's core vision. Founded in 2004, employee-owned PDA empowers thousands of dentists internationally so they can make confident decisions as a leader, re-engage their passion, and achieve financial and personal satisfaction. For more information, call 800-757-6077, email info@productivedentist.com, or visit http://www.productivedentist.com.

Balanced Pharma Incorporated (BPI) announced today the acquisition of rights to a promising new non-opioid injectable post-surgical pain relief drug, Enduracaine Dental™, for the worldwide dental market.

BPI aims first to capture a share of the $1.4 billion U.S. market potential for multi-day, non-opioid pain relief after wisdom tooth and other dental surgical procedures. Target improvements over current products include three days of analgesia, low toxicity, less need for opioids, and convenient packaging in standard dental cartridges.

Studies show that 94% of patients currently receive an opioid prescription following a wisdom tooth extraction¹ and an alarming 14 times greater risk of opioid abuse following those prescriptions.²

As the nation continues to grapple with the ongoing opioid epidemic, Balanced Pharma believes adding Enduracaine Dental to its development pipeline will expand its offering of improved pain management tools for dental professionals, and hopes to significantly reduce the number of opioid prescriptions.

Enduracaine is a patented combination of tetracaine 0.2%, lidocaine 0.4%, and epinephrine 1:250,000 introduced to the surgical market in 2023 as Endura-KT (a compounding kit) by Ventis Pharma. While the drug performance has been well received by practitioners in multiple specialties, including Oral & Maxillofacial Surgery, the kit presentation of the product has usability challenges including a short shelf-life and the need for refrigeration and reconstitution. For dental surgeons, incompatibility with standard dental syringes is a further barrier to rapid adoption.

BPI will use their patented technology to provide Enduracaine Dental in a standard dental cartridge, with a two-year shelf-life and no need for reconstitution or refrigeration.

“If we can give doctors a safe, non-opioid drug with three days of analgesia for their patients, in a standard dental cartridge that is efficient for their practice, that is an absolute win,” says BPI CEO Dr. Scott Keadle, a retired dentist.

“We are pleased to partner with Balanced Pharma to make our Enduracaine™ local anesthetic easier to use for dental surgeons,” says Dr. Lou Stanfield, Chief Scientific Officer at Ventis Pharma. “The Ventis drug delivered in the BPI cartridge is just what the doctor ordered, and we look forward to rapid adoption of this new product presentation by our current dental customers and across the dental surgical indication.”

Dr. Keadle adds, “We are honored to partner with Ventis Pharma and dental professionals to offer patients and families the chance to lower the risk of pain and opioid associated problems after dental surgery.”

Enduracaine Dental and all BPI products are currently in development, have not yet been approved by the FDA, and are not available for marketing or sale in the United States.

BPI intends to make Enduracaine Dental available to dental professionals within the next 12 months.

About Balanced Pharma, Inc.

Balanced Pharma, Inc. (BPI) is a pharmaceutical company based in Cornelius, North Carolina, focused on patient comfort and safety, and is currently developing BPI-001 and BPI-002, which are intended to reduce injection pain, speed the onset of anesthesia, and increase the success rate of local anesthetic injections. Enduracaine Dental (BPI-004) will add to the list of BPI products that are currently in development.

All BPI products are currently in development, have not been approved by the FDA, and are not available for marketing or sale in the United States.

Website: https://balancedpharma.com

BPI products have not yet been approved by the FDA and are not available for sale.

About Ventis Pharma

Website: https://ventispharma.com

References

1. “100 Million Prescription Opioids Go Unused Each Year Following Wisdom Teeth Removal,” Penn Medicine News, September 22, 2016

2. “Study: Dental painkillers may put young people at risk of opioid addiction,” The Washington Post, Ronnie Cohen, December 3, 2018

Thomas Jackson, a practicing periodontist, prosthodontist, and successful inventor, recently founded Smyles Above Innovations Inc., a company dedicated to developing and commercializing leading-edge dental devices and oral care products that support the continuum of dental implant success from placement to maintenance, and advanced flossing tools for hard to access oral appliances.

Dr. Jackson will formally introduce Smyles Above Innovations during The Shils Entrepreneurial Fund’s “Great Oral Health Pitch,” which is taking place at the 2024 Greater New York Dental Meeting on Monday, starting at 2:30 PM.

According to Dr. Jackson, “Smyles Above was established to incorporate my two existing products IrriGUIDE and The AutoFlosser under one corporate umbrella to create more effective synergy and salability across our branding, operations and sales and to make our company more efficient and more attractive to investors.”

Dr. Jackson’s goal for additional funding is to invest in additional product development and to expand the sales and marketing support of his two existing and well-received product innovations:

IrriGUIDE: An easy-to-install retrofit adapter developed by Dr. Jackson for any dental implant surgical guide system. IrriGUIDE enables saline to flow through the guide and directly irrigate and cool the implant osteotomy to keep it below the critical temperature threshold of 47°.

According to Brian Vence, DDS, “The IrriGUIDE System ensures the best chance of osseointegration by preserving vital bone. It’s a great contribution to guided surgery.” See more IrriGUIDE details at https://irriguide.com/.

The AutoFlosser: A unique dental floss solution specifically designed by Dr. Jackson to alleviate flossing difficulties for all-on-X patients and anyone who has been fitted with connected or solid appliances such as implants, bridges, braces, and bonded retainers.

Hygiene KOL Lynn Pencek, RDH says, “The AutoFlosser helps patients easily direct floss in the harder-to-reach areas. It is ideal for patients with poor dexterity.” For more details on The AutoFlosser, visit https://theautoflosser.com/

In addition to expanding awareness and market share for IrriGUIDE and The AutoFlosser, Dr. Jackson intends to use investor funding to fully commercialize several other inventions and business model plans that he has in the pipeline, “My long-term goal for Smyles Above is to be a respected launchpad of innovative clinical and consumer solutions for the advancement of better oral health.”

Interested investors and distributors can contact Dr. Jackson directly at tjackson@SmylesAbove.com.

About Smyles Above Innovations, Inc.: Founded in 2024 in Barrington, IL by practicing periodontist and prosthodontist, Thomas Jackson, DDS; Smyles Above Innovations, Inc. is dedicated to developing and launching leading-edge dental devices and oral care products that support the continuum of dental implant success from placement to maintenance, and advanced flossing tools for hard to access oral appliances.

The company is currently selling two innovative products – The IrriGUIDE Irrigated Implant Surgical Guide and The AutoFlosser Flossing Solution. For more information, visit www.SmylesAbove.com.

Zahn Dental, the U.S. dental laboratory business of Henry Schein, Inc. (HSIC: Nasdaq), announced a robust schedule of in-person and virtual opportunities through the end of 2024. Available from Zahn Academy, dental laboratory owners and technicians can take advantage of end-of-year educational courses and learn more about the application of the latest innovations and industry trends.

Educational opportunities from Zahn Dental are available via online webinars, in-person roadshows, and hands-on simulations. New this year, Zahn Dental launched its podcast, “Zahn Insider.” On the first episode, Mark Palmer, Vice President & General Manager of Zahn Dental, addressed how dental labs can effectively implement Six Sigma in production and workflow processes, as well as the benefits of Zahn’s newest state-of-the-art distribution center. In 2025, Zahn plans to produce new podcasts each quarter.

“At Zahn Dental, our multi-channel educational resources meet customers where they are, helping to deliver more flexible and convenient options to receive the latest insights and innovations from industry experts,” said Mr. Palmer.

The following events are available both virtually and in-person through the remainder of 2024.

NOVEMBER

• 11/6 – Full Arch Hybrids: Planning and Material Options (Webinar)

• 11/13 – Denture Conversions 101 (Webinar)

• 11/15 – Zahn Expo: Your Roadmap to Integrated Digital Workflow Solutions (Roadshow)

• 11/20 – Zirconia Restorative Solutions: From Monolithic to Layered (Webinar)

DECEMBER

• 12/4 – An Easy Path to FDA Validated Milled Abutments in Your Lab (Webinar)

• 12/11 – Denture Conversions: Digital Workflow and Patient Case From Start to Insert (Webinar)

In addition to its educational line-up for the remainder of the year, Zahn Dental will be onsite at LMT LAB DAY Chicago in February 2025 with additional courses to be announced.

For dental labs unable to attend these upcoming events, or missed those that have passed, Zahn Academy offers on-demand webinars that can be found by visiting, https://www.youtube.com/@ZahnDentalLab/videos. 

About Zahn Dental

Zahn Dental, the dental laboratory business of Henry Schein, is a leading distributor of CAD/CAM equipment, digital materials, removable prosthetic teeth, and traditional core supplies to dental laboratories in North America. Zahn adds a full-service support, training and repair department and R&D to provide solutions for laboratories, and is dedicated to providing the best technology to help labs provide the best products to their clinicians. The business offers a comprehensive, industry-leading selection of innovative products, breakthrough technologies, value-added services, and technical support that make Zahn a total solution provider.

Laboratories can rely on Zahn's highly trained and knowledgeable specialists, consultants, support technicians, and Team Schein Members to deliver everything a laboratory needs to thrive and succeed. For more information, visit www.zahndental.com.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 25,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com.

Pictured: Zahn Dental has launched a podcast, ‘Zahn Insider.’

Today Integral Dental announces the launch of its first product, Oracle^PI, the only early diagnostic test for peri-implant disease. The test delivers a disease diagnosis and personalized care plan recommendations based on patient specific data. Dental implants represent an important option for patients with missing teeth. While implant success rates are high, the greatest risk of failure is an infection of the surrounding tissue, called peri-implantitis. Integral’s new product, Oracle^PI enables clinicians to gain insight into 100% of the bacteria present at the implant site, diagnoses the state of infection, and makes recommendations on most effective antibiotics and other treatments. “This has the potential to improve patient outcomes and drive profitability for dental practices,” said Rachel Raymond, CEO of Integral Dental. “As the demand for implants grows, we’re excited to offer an option for personalized management.”

By combining cutting-edge genomic sequencing and AI, Oracle^PI empowers dentists with actionable insights to improve patient outcomes through personalized care. “We’ve worked hard to make sure our processes fit seamlessly into the daily workflow of the dental office,” said Matt Getz, COO of Integral Dental, “Our $110/test cost to dentists is part of the innovation we’re bringing to the table.” Earlier interventions in peri-implant disease are often more effective and less invasive than if they are performed at more advanced stages of infection. Performing a diagnostic test as part of routine implant management can help clinicians identify problems early and keep their patients healthy. “The specific antibiotic recommendations give us the opportunity to practice true personalized medicine,” said Dr. Peter Joseph, DMD, Clinical Advisor to Integral Dental, “I plan to integrate this tool into my practice and ask all my referring doctors to do the same. The better the information, the better we can help patients.”

Diagnosing peri-implant disease is just the beginning for Integral’s technology platform. Integral’s vision extends beyond oral health to addressing systemic diseases triggered by oral pathogens, such as cardiovascular disease, pre-term birth, rheumatoid arthritis, and colon cancer. When we diagnose and treat oral pathogens early and effectively, healthcare costs reduce precipitously, and patient outcomes improve. Integral Dental continues to explore innovative applications for Oracle^PI, building bridges between oral health and broader medical care.

Call to Action: Oracle^PI is now available for purchase and is being offered in 10 kit packs for a limited time. To learn more and add Integral to the services offering your patients, visit IntegralDental.bio.

About Integral: Integral is a biotechnology company dedicated to closing the gap between oral and systemic health. The innovation is based on Next Generation Sequencing and Machine Learning technology and driven by co-founders Rachel Raymond and Matt Getz. The founders bring extensive biotech and healthcare executive experience, MBAs from Harvard Business School, and a passion for preventative medicine to this large, global health problem. Integral is a resident company of Johnson & Johnson Innovation - JLABS, a premier life science incubator program in Washington, DC.